CHOP [China Gerui Advanced Materials] UPLOAD: (Original Filing)
[]
CNR [CHINA METRO-RURAL] SC 13G: (Original Filing)
[CUSIP No. G3163G104 13G Page x of x Pages]
CNR [CHINA METRO-RURAL] SC 13G: CUSIP No. G3163G104 13G Page x of x
[CUSIP No. G3163G104 13G Page x of x Pages]
VIMC [Vimicro International] 6-K: (Original Filing)
[First Quarter 2011 Results First Quarter 2011 Results Net revenue in the first quarter of 2011 was $13.0 million, compared to $18.9 million in the first quarter of 2010 and $24.4 million in the fourth quarter of 2010. (Figures from prior periods have been restated to account for discontinued operations following the divestiture of non-core IC businesses in December 2010.)]
VIMC [Vimicro International] 6-K: First Quarter 2011 Results First Quarter 2011 Results
[First Quarter 2011 Results First Quarter 2011 Results Net revenue in the first quarter of 2011 was $13.0 million, compared to $18.9 million in the first quarter of 2010 and $24.4 million in the fourth quarter of 2010. (Figures from prior periods have been restated to account for discontinued operations following the divestiture of non-core IC businesses in December 2010.)]
VIMC [Vimicro International] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4]
SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)
[This Form 6-K consists of: (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) NOTICE OF BOARD MEETING]
SNP [CHINA PETROLEUM & CHEMICAL] 6-K: This Form 6-K consists of: (a joint stock
[This Form 6-K consists of: (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) NOTICE OF BOARD MEETING]
CBPO [China Biologic Products] 8-K: (Original Filing)
[China Biologics 2 Plasma Collection Stations in Guizhou Province Have Been Inspected and Relicensed, 4 Other Stations in Disallowed Counties Closed on August 1, 2011 TAIAN, China, August 1, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic, or the Company), a leading plasma-based biopharmaceutical company in China, today announced that 2 of its plasma collection stations, in] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 1, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]
